Perennial Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Perennial Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis
Clinical trial update on the efficacy, safety, and tolerability of a 4-week regimen of ciclesonide nasal spray (200 mcg) for intermittent an…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety of Ciclesonide, Applied as a Nasal Spray at Three Dose Levels, in the Treatment of Perennial Allergic Rhinitis in Pediatrics (BY9010/M1-405) [Phase 3]
A Phase 3 trial evaluating the safety of three dose levels of ciclesonide nasal spray for perennial allergic rhinitis in pediatric patients …
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) [Phase 3]
Phase 3 clinical trial evaluating safety and efficacy of ciclesonide nasal spray for perennial allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: Investigation of Potential Additive Inhibitory Effects on HPA-Axis of Ciclesonide Nasal Spray When Administered Concomitantly With Orally Inhaled Beclomethasone Dipropionate (HFA-BDP) in Patients With Perennial Allergic Rhinitis (PAR) (BY9010/M1-408) [Phase 3]
Phase 3 study evaluating potential additive inhibition of the HPA axis when ciclesonide nasal spray is used with orally inhaled beclomethaso…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416) [Phase 3]
A Phase 3 study evaluated the safety and tolerability of ciclesonide nasal spray in children aged 2-5 with perennial allergic rhinitis; the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490) [Phase 4]
Clinical trial update noting the completion of a Phase 4 study evaluating the combination of ciclesonide nasal spray and azelastine nasal sp…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR). [Phase 3]
A Phase 3 study evaluating the efficacy and safety of a once-daily investigational nasal spray in adults and adolescents with perennial alle…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics [Phase 3]
Clinical trial update noting the completion of a Phase 3 study of GW685698X for perennial allergic rhinitis in pediatric patients.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray [Phase 3]
Phase 3 safety trial in children with seasonal and perennial allergic rhinitis evaluating GW685698X aqueous nasal spray versus placebo has c…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Seasonal Allergic Rhinitis In Pediatric Subjects [Phase 3]
Phase 3 pediatric trial update for seasonal and perennial allergic rhinitis sponsored by GlaxoSmithKline; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study of GW685698X for the Treatment Of Perennial Allergic Rhinitis in Adolescents and Adults [Phase 3]
Phase 3 study of GW685698X for perennial allergic rhinitis in adolescents and adults has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis. [Phase 3]
Phase 3 clinical trial evaluating the effectiveness of two loratadine-pseudoephedrine preparations in patients with perennial allergic rhini…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: A Study in Subjects With Perennial Allergic Rhinitis [Phase 2]
A Phase 2 clinical trial in perennial allergic rhinitis conducted by Merck Sharp & Dohme has completed.
-
CLINICAL_TRIALS trial_result · 2015-12-15Clinical Trial Update: The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]
A confirmatory Phase 3 study of TAU-284 in pediatric patients with perennial allergic rhinitis has completed and posted results. The study w…
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]
Tanabe's TAU-284 completed a long-term Phase 3 study in pediatric patients with perennial allergic rhinitis; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR) [Phase 3]
Phase 3 trial update on hypothalamic-pituitary-adrenal axis safety in pediatric perennial allergic rhinitis; the study is completed and resu…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of eN-Lac® capsules (Lactobacillus paracasei GMNL-32) in children with perennial a…
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428) [Phase 4]
Phase 4 trial reports on the efficacy and safety of Loratadine-Betamethasone oral solution for severe perennial allergic rhinitis in childre…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
This clinical trial update describes observational usage of Loratadine (Claritin) in pediatric patients using tablet, RediTabs, and dry syru…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: The Role of Montelukast in Rhinitis and Sleep [Phase 4]
Phase 4 clinical trial evaluated montelukast for perennial allergic rhinitis and sleep outcomes; results were posted in 2014. The study was …
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Study of the Safety and Pharmacokinetics of Montelukast (MK-0476) in the Treatment of Japanese Pediatric Participants With Perennial Allergic Rhinitis (MK-0476-520) [Phase 3]
Phase 3 clinical trial studying the safety and pharmacokinetics of montelukast in Japanese children with perennial allergic rhinitis has com…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® Tablet
A completed postmarketing surveillance study evaluating the safety and efficacy information of Alesion® Tablet in perennial allergic rhiniti…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis [Phase 4]
Phase 4 trial comparing Fluticasone propionate nasal spray to cetirizine for seasonal allergic rhinitis, with results posted after completio…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of desloratadine (MK-4117) in Japanese participants with perennial allergic rhinitis has co…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR) [Phase 4]
Phase 4 safety study evaluating 6 months of ciclesonide nasal aerosol (Zetonna) and ciclesonide nasal spray (Omnaris) in subjects aged 12 ye…